Diagnosis Codes in MS-DRG 837 - Chemotherapy With Acute Leukemia As Secondary Diagnosis Or With High Dose Chemotherapy Agent With MCC
The Medicare Severity Diagnosis-Related Group (MS-DRG) is a patient classification system used to categorize hospital cases based on clinical similarity and expected resource use. MS-DRGs organize all possible principal diagnoses into mutually exclusive groups known as Major Diagnostic Categories (MDCs), which help determine reimbursement under the Medicare Inpatient Prospective Payment System.
This section lists the diagnosis codes included in MS-DRG V42.0: Chemotherapy with Acute Leukemia as Secondary Diagnosis or with High Dose Chemotherapy Agent with MCC from October 1, 2024, through September 30, 2025.
MS-DRG: 837
MS-DRG Title: Chemotherapy with Acute Leukemia as Secondary Diagnosis or with High Dose Chemotherapy Agent with MCC
MCD: 17
Relative Weight: 5.0068 Relative Weight
The relative weight of a diagnostic related group determines the reimbursement rate based on the severity of a patient's illness and the associated cost of care during hospitalization.
Arithmetic LOS: 10.40 Arithmetic Length of Stay
The average length of stay (ALOS) reflects the average number of days a patient spends in a hospital for each admission.
- C91.0 - Acute lymphoblastic leukemia [ALL]
- C92.0 - Acute myeloblastic leukemia
- C92.4 - Acute promyelocytic leukemia
- C92.5 - Acute myelomonocytic leukemia
- C92.6 - Acute myeloid leukemia with 11q23-abnormality
- C92.A - Acute myeloid leukemia with multilineage dysplasia
- C93.0 - Acute monoblastic/monocytic leukemia
- C94.0 - Acute erythroid leukemia
- C94.2 - Acute megakaryoblastic leukemia
- C94.4 - Acute panmyelosis with myelofibrosis
- C95.0 - Acute leukemia of unspecified cell type
- Z51.1 - Encounter for antineoplastic chemotherapy and immuno
-
Z08 - Encounter for follow-up examination after completed treatment for malignant neoplasm
C91.0 - Acute lymphoblastic leukemia [ALL]
C92.0 - Acute myeloblastic leukemia
C92.4 - Acute promyelocytic leukemia
C92.5 - Acute myelomonocytic leukemia
C92.6 - Acute myeloid leukemia with 11q23-abnormality
C92.A - Acute myeloid leukemia with multilineage dysplasia
C93.0 - Acute monoblastic/monocytic leukemia
C94.0 - Acute erythroid leukemia
C94.2 - Acute megakaryoblastic leukemia
C94.4 - Acute panmyelosis with myelofibrosis
C95.0 - Acute leukemia of unspecified cell type
Z51.1 - Encounter for antineoplastic chemotherapy and immunotherapy